Peaceful Hearts-B: The National Medical Products Administration has approved the registration of BIOHEART bioresorbable drug-eluting stent.

Bai Xinan-B announces that on June 29, 2029, the Bioheart biodegradable drug-eluting stent, developed independently by our company, has been approved by the National Medical Products Administration of the People's Republic of China for the treatment of ischemic heart disease patients with native coronary artery lesions in order to improve coronary artery lumen diameter. The detailed results of the Bioheart BRS pivotal trial have been published in "JACC: Cardiovascular Interventions."